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A B S T R A C T
It is widely known that an elevated body weight correlates with
increased bone mass and a lower rate of bone loss. However, some
authors have suggested that excessive fat mass may not protect
against a decrease in bone mass. As results of recent studies have
diverged, and it is still unclear whether or not obesity has a bene-
ficial effect on bone, we decided to evaluate the individual abso-
lute fracture risk in obese perimenopausal women.
Sixty obese perimenopausal women were enrolled into the study.
The control group consisted of 15 healthy women of comparable
age. Dual energy X-ray absorptiometry (DXA) of the lumbar spine
and femoral neck to measure bone mineral density (BMD) was per-
formed using the Lunar DPXL apparatus. Absolute 10-year fracture
risk was calculated as a multiplication of relative risk, according to
the guidelines of the WHO/Polish Foundation of Osteoporosis.
Obese women have significantly a higher BMD both of the lumbar
spine and the femoral neck and a significantly lower 10-year abso-
lute fracture risk in comparison to healthy controls.
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S T R E S Z C Z E N I E
Powszechnie uznaje się, że większa masa ciała wiąże się z większą
gęstością mineralną kości oraz zmniejszonym tempem ubytku
masy kostnej. Z drugiej strony, pojawiają się prace, w których au-
torzy donoszą, że nadmiar tkanki tłuszczowej nie wykazuje ochron-
nego wpływu na ubytek masy kostnej. Ponieważ wyniki dostęp-
nych badań są rozbieżne i nie pozwalają na jednoznaczne wnio-
skowanie co do wpływu otyłości na tkankę kostną, autorzy pracy
zdecydowali się ocenić 10-letnie bezwzględne ryzyko złamania
u otyłych kobiet w wieku okołomenopauzalnym.
Badaniem objęto grupę 60 otyłych kobiet. Grupę kontrolną stano-
wiło 15 zdrowych kobiet w porównywalnym wieku. Badanie gę-
stości mineralnej kości w obrębie szyjki kości udowej oraz odcin-
ka lędźwiowego kręgosłupa wykonano metodą absorpcjometrii
podwójnej energii promieniowania rentgenowskiego przy użyciu
aparatu Lunar DPXL. Dziesięcioletnie bezwzględne ryzyko złama-
nia obliczono zgodnie z zaleceniami Światowej Organizacji Zdro-
wia/Polskiej Fundacji Osteoporozy. Otyłe kobiety charakteryzowały
się większą gęstością mineralną kości w obrębie szyjki kości udo-
wej oraz odcinka lędźwiowego kręgosłupa oraz mniejszym10-let-
nim bezwzględnym ryzykiem złamania w porównaniu z kobietami
z prawidłową masą ciała.
Słowa kluczowe: otyłość, ryzyko złamania, BMD
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Introduction
Obesity and osteoporosis are two common com-
plex diseases of multifactorial aetiologies. Both have
65
www.endokrynologia.viamedica.pl
Michał Holecki i wsp., Fracture risk and obesity
grown in prevalence over the past decade and both
are associated with significant morbidity and mortality
[1–3]. It is widely known that an elevated body weight
is correlated with increased bone mass and a lower
rate of bone loss [4, 5]. Additionally, a decrease in body
weight may lead to bone loss [6, 7]. Some evidence
does support the view that elevated fat mass has
a beneficial effect on bone mass; in premenopausal and
postmenopausal women body fat has been positively
correlated to bone mineral density (BMD) through the
skeleton [8, 9] The EPIC Study also showed that rapid
bone losers are characterised by significantly lower fat
mass than slow bone losers [10].
In contrast to these findings, other authors have sug-
gested that excessive fat mass may not protect against
a decrease in bone mass [11]. Therefore, when the me-
chanical loading effect of body weight is statistically remo-
ved, fat mass correlates negatively with bone mass [12].
Other authors have indicated that the relationship
between obesity and the risk of fracture is related to
age. Wearing et al. reported that elevated adiposity was
considered to be associated with an increased risk of
distal forearm fracture in children but turned out to be
protective against hip fractures in the elderly [13].
As the results of recent studies have been divergent,
and it is still unclear whether or not obesity has a bene-
ficial effect on bone, we decided to evaluate individual
absolute fracture risk in obese perimenopausal women.
Experimental procedures
Sixty obese perimenopausal women (BMI 36.4 ±
± 4.2 kg/m2; age 50 ± 5.3 yrs) were enrolled into the
study. All subjects gave their written informed consent
before entering the study. Excluded from the study were
subjects with diseases, undergoing treatments or with
conditions that would be causes of abnormal bone
mass or fat mass, such as smoking, consuming more
than two drinks a week or hormonal disturbances. The
control group consisted of 15 healthy, non-obese wo-
men of comparable age (BMI 23 ± 1.3 kg/m2; 53.7 ±
± 5.6 yrs).
BMI was calculated as weight in kg divided by the
square of the height (m2).
Body composition was assessed using the impe-
dance method (Bodystat).
Dual energy X-ray absorptiometry (DXA) of the lum-
bar spine and femoral neck to measure BMD was per-
formed using the Lunar DPXL apparatus.
Absolute 10-year fracture risk (AR-10) was calcula-
ted according to the guidelines of the WHO and Polish
Foundation of Osteoporosis [14, 23]. This was calcu-
lated by multiplying the population risk (in percenta-
ges) by relative risk (RR) values defined for consecuti-
ve unrelated independent factors of fracture risk and
possibly also RR resulting from BMD.
The calculator for the AR-10 consisted of the following:
1. 10-year fracture risk of the proximal femur in a po-
pulation of women of various ages (PR-10) (Table
1) [15].
2. RR values of proximal femur fracture in relation to
the value of BMI (Table 2) [11].
3. RR for given fracture risk factors (Table 3) [16–21].
4. RR of proximal femur fracture with a decrease in
the Z-score in the proximal femur (Table 4) [22].
AR-10 = PR-10 × RRBMI × Product RR × RR for a decre-
ase in the Z-score in the proximal femur [23]
All values presented in the text and tables are expres-
sed as means ± S.D. All analyses were performed using
the Statistica computer program. The normality of distri-
bution was analysed using the Kołmogorov-Smirnov test.
The Mann-Whitney pair-wise U test was used for com-
Table 4. RR of proximal femur fracture with a decrease
of  Z-score in the proximal femur [22]
Z-score –0.5 –1.0 –1.5 –2.0 –2.5 –3.0
RR 1.6 2.6 4.2 6.8 10.9 17.6
Table 1. 10-year fracture risk of the proximal femur in
a population of women of different ages (AR-10) [15]
Women (age) 45 50 55 60 65 70 75 80 85
Risk (PR-10) 0.4 0.6 1.2 2.3 3.9 7.3 11.7 15.5 16.1
Table 2. RR values of proximal femur fracture in relation
to the value of BMI [11]
BMI 15 20 25 30 35
RR 4.48 1.95 1.0 0.83 0.75
Table 3. RR for given fracture risk factors [16–21]
Risk factors RR
Prior fragility fracture after age 50 1.85
Parental history of hip fracture 2.27
Secondary osteoporosis 1.95
Use of corticosteroids at any time 2.07 — W 2.6 — M
Current cigarette smoking 1.84
Alcohol intake > units/day 1.68
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parison of independent samples. The results were ana-
lysed using Spearman’s correlation analysis. P values
< 0.05 were considered to be significant.
Results
Obese subjects had a significantly higher BMD both
of the lumbar spine and the femoral neck and a lower
AR-10 in comparison with the healthy controls (Tables
5 and 6). We observed a negative correlation between
AR-10 and the BMD of both the femoral neck and the
lumbar spine (p = 0.000 r = –0.49; p = 0.0000,
r = –0.45; respectively). There was a negative correla-
tion between body fat and the T-score of the lumbar
spine (r = –0.26; p < 0.05). There were no significant
correlations between body fat content and either BMD
or the Z-score of the lumbar spine and the T and
Z-scores of the femoral neck.
Discussion
BMD has been widely accepted as the criterion in
the diagnosis or exclusion of osteoporosis. The WHO
accepted the diagnostic threshold of a T-score of –2.5 as
a value that qualifies patients for treatment for oste-
oporosis [24]. However, recent studies of fracture epi-
demiology have indicated that up to 75% of these frac-
tures occur in persons with a T-score around –1.5, so
with bone mass on the borderline between the norm
and osteopoenia [25, 26]. Thus the majority of patients
with fractures do not fulfil the densitometric criteria for
osteoporosis set by the WHO in 1994, namely a decre-
ase in bone mass with a deterioration in the microarchi-
tecture. The conclusion to be drawn from these studies is
that decreased bone mineral density increases fracture
risk but normal values do not exclude it. The patients
mentioned above were burdened with causes of lower
bone strength other than low bone mass. Following on
from these results, it emerges that a diagnosis based only
on BMD and age reduces the possibility of determining
fracture risk. This is why when evaluating risk fracture we
have to take into consideration many other parameters
that influence bone mass, including alcohol intake, smo-
king, BMI, fat mass and physical activity.
Obese subjects are known to have a decreased
level of physical activity and sun exposure, an unba-
lanced diet, a higher serum level of parathormone and
a lower serum level of vitamin D3 in comparison with
lean subjects [27]. Obese subjects also have a lower
level of osteoprotegerin, supposed to be one of the
factors protecting against bone loss [28]. All of these
observed factors may lead to abnormal bone meta-
bolism. Moreover, a recently published meta-analy-
sis revealed that obesity is not a protective factor aga-
inst osteoporosis [11].
In our study we have evaluated AR-10 using multiple
clinical risk factors. We were able to exclude the influence
of potential chronic disease, as our study group consisted
of healthy obese subjects. Our obese subjects were cha-
racterised by statistically higher bone mineral density, both
in the lumbar spine and femoral neck, and a significantly
lower AR-10 in comparison to non-obese subjects. This
would support the notion that obesity does have a pro-
tective influence on bone. In contrast to the results pre-
Table 5. BMD of the lumbar spine, femoral neck and body composition in obese perimenopausal women in comparison
to controls (means ± SD)
Subjects Controls Significancy
BMD of L1-L4 [g/cm
2] 1.26 ± 0.17 1.07 ± 0.12 p < 0.0005
BMD of femoral neck [g/cm2] 1.09 ± 0.17 0.83 ± 0.10 p= 0.000000
Body fat (%) 48.69 ± 6.63 33.16 ± 4.77 p = 0.000000
Fat-free mass (%) 50.92 ± 6.31 66.82 ± 4.76 p = 0.000000
Table 6. 10-year absolute fracture risk (AR-10) (%) in obese perimenopausal women in comparison to controls (means ± SD)
Subjects Controls Significancy
AR-10 for L1-L4 0.3 ± 0.56 2.27 ± 1.49 p = 0.000000
AR-10 for hip 0.28 ± 0.76 2.23 ± 2.69 p = 0.000000
AR-10 total 0.88 ± 0.77 2.20 ± 1.32 p = 0.000000
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viously mentioned we did not find any correlation betwe-
en body fat content and either BMD or T and Z-scores in
the femoral neck. We found a negative relation between
body fat and the T-score of the lumbar spine.
However, it is still unclear if fat body mass (FMB) or
lean body mass (LBM) determines BMD, as authors
have used different ways of measuring bone mass and
have presented diverging results. Khosla et al. [29]
suggested that the relationship between body compo-
sition and bone mass is strictly dependent on which
bone mass parameter, whether bone mineral content
(BMC) or BMD, is used in the analysis. The authors
demonstrated that both LBM and FMB have important
effects on bone mass, depending on the bone mass
parameter used, skeletal site measured and menopau-
sal status. In premenopausal and postmenopausal
women both LBM and FBM predicted total BMC. LBM
had a dominant effect on spine and forearm BMC in
both groups and hip BMC in premenopausal women,
whereas both LBM and FBM predicted hip BMC in
postmenopausal women [29].
As mentioned in the introduction, studies demon-
strate either a positive or negative effect of body fat
mass on bone. Some suggest that fat mass, as a body
mass component and direct index of obesity, has
a protective effect on bone tissue, thereby reducing the
risk of osteoporosis [8, 30]. Lau et al. [31] showed that
males with vertebral deformities had a lower fat mass
and BMD than controls. The other data provided evi-
dence that excessive fat mass may not protect against
a decrease in bone mass [11, 32]. Moreover, they do-
cumented a negative relation between fat mass and
bone mineral density and suggested that fat mass has
a detrimental effect on bone [12]. Consistent with the-
se findings, Hsu et al. [33] observed a higher risk of
osteopoenia, osteoporosis and non-spinal fractures in
patients with a greater fat mass, independent of body
weight. Other authors indicated that ethnicity may in-
fluence the effect of fat mass on bone metabolism.
Castro et al. [34] reported that obesity was associated
with a high BMD in white women but with a significant
decrease in African American women. Wearing et al.
[35] indicated that the relationship between risk of frac-
ture and obesity is related to age; a high fat mass in
children is associated with an increased risk of distal
forearm in children but appears to be protective aga-
inst hip fracture in the elderly.
These divergent findings suggest that the effect of
fat mass on bone may be very complex and that re-
sults may be attributed to factors such as methods of
analysis, menopausal status in women, study design,
gender and age.
Following our results we conclude that even tho-
ugh obesity is associated with significant mortality and
morbidity, its influence on bone is beneficial.
Conclusion
Obese perimenopausal women are characterised by
a significantly lower 10-year absolute fracture risk in
comparison to healthy women of normal body weight.
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